Fructose normalizes specific counterregulatory responses to hypoglycemia in patients with type 1 diabetes

Diabetes

Volumn 54, Issue 3, 2005, Pages 609-616

  Gabriely, Ilan ^a   Shamoon, Harry ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; FRUCTOSE; GLUCAGON; GLUCOKINASE; GROWTH HORMONE; HEMOGLOBIN A1C; HYDROCORTISONE; INSULIN; NORADRENALIN; REGULATOR PROTEIN;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CATALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; GLUCOSE INFUSION; GROWTH HORMONE BLOOD LEVEL; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FEMALE; FRUCTOSE; GLUCOKINASE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIA; INFUSIONS, INTRAVENOUS; INSULIN; MALE; TIME FACTORS;

EID: 14644432411     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.3.609     Document Type: Article

References (45)

1. Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care 26:1902-1912, 2003
2. Gabriely I, Shamoon H: Hypoglycemia in diabetes: common, often unrecognized. Cleve Clin J Med 71:335-342, 2004
3. Bolli GB: Treatment and prevention of hypoglycemia and its unawareness in type 1 diabetes mellitus. Rev Endocr Metab Disord 4:335-341, 2003
4. Bolli GB: Counterregulatory mechanisms to insulin-induced hypoglycemia in humans: relevance to the problem of intensive treatment of IDDM. J Pediatr Endocrinol Metab 11 (Suppl. 1):103-115, 1998
5. Kleinbaum J, Shamoon H: Impaired counterregulation of hypoglycemia in insulin-dependent diabetes mellitus. Diabetes 32:493-498, 1983
6. Mitrakou A, Ryan C, Veneman T, Mokan M, Jenssen T, Kiss I, Durrant J, Cryer P, Gerich J: Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction. Am J Physiol 260:E67-E74, 1991
7. Mevorach M, Kaplan J, Chang CJ, Rossetti L, Shamoon H: Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus. Am J Physiol Endocrinol Metab 278:E421-E429, 2000
8. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
9. Efrat S, Tal M, Lodish HF: The pancreatic beta-cell glucose sensor. Trends Biochem Sci 19:535-038, 1994
10. German MS: Glucose sensing in pancreatic islet beta cells: the key role of glucokinase and the glycolytic intermediates. Proc Natl Acad Sci U S A 90:1781-1785, 1993
11. Mueckler M: Glucokinase, glucose sensing, and diabetes. Proc Natl Acad Sci U S A 90:784-785, 1993
12. Levin BE: Metabolic sensors: viewing glucosensing neurons from a broader perspective. Physiol Behav 76:397-401, 2002
13. Routh VH, Song Z, Liu X: The role of glucosensing neurons in the detection of hypoglycemia. Diabetes Technol Ther 6:413-421, 2004
14. Van Schaftingen E, Veiga-da-Cunha M, Niculescu L: The regulatory protein of glucokinase. Biochem Soc Trans 25:136-140, 1997
15. Veiga-da-Cunha M, Van Schaftingen E: Identification of fructose 6-phosphate- and fructose 1-phosphate-binding residues in the regulatory protein of glucokinase. J Biol Chem 277:8466-8473, 2002
16. Penicaud L, Leloup C, Lorsignol A, Alquier T, Guillod E: Brain glucose sensing mechanism and glucose homeostasis. Curr Opin Clin Nutr Metab Care 5:539-543, 2002
17. Smith D, Pernet A, Reid H, Bingham E, Rosenthal JM, Macdonald IA, Umpleby AM, Amiel SA: The role of hepatic portal glucose sensing in modulating responses to hypoglycaemia in man. Diabetologia 45:1416-1424, 2002
18. Maekawa F, Toyoda Y, Torii N, Miwa I, Thompson RC, Foster DL, Tsukahara S, Tsukamura H, Maeda K: Localization of glucokinase-like immunoreactivity in the rat lower brain stem: for possible location of brain glucose-sensing mechanisms. Endocrinology 141:375-384, 2000
19. Mobbs CV, Kow LM, Yang XJ: Brain glucose-sensing mechanisms: ubiquitous silencing by aglycemia vs. hypothalamic neuroendocrine responses. Am J Physiol Endocrinol Metab 281:E649-E654, 2001
20. Yang XJ, Kow LM, Funabashi T, Mobbs CV: Hypothalamic glucose sensor: similarities to and differences from pancreatic β-cell mechanisms. Diabetes 48:1763-1772, 1999
21. Gabriely I, Hawkins M, Vilcu C, Rossetti L, Shamoon H: Fructose amplifies counterregulatory responses to hypoglycemia in humans. Diabetes 51:893-900, 2002
22. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic-euglycemic glucose clamps: comparison of unlabeled and labeled exogenous glucose infusates. Diabetes 36:914-924, 1987
23. Shiota M, Galassetti P, Monohan M, Neal DW, Cherrington AD: Small amounts of fructose markedly augment net hepatic glucose uptake in the conscious dog. Diabetes 47:867-873, 1998
24. Hawkins M, Gabriely I, Wozniak R, Vilcu C, Shamoon H, Rossetti L: Fructose improves the ability of hyperglycemia per se to regulate glucose production in type 2 diabetes. Diabetes 51:606-614, 2002
25. Tounian P, Schneller P, Henry S, Jequier E, Tappy L: Effects of infused fructose on endogenous glucose production, gluconeogenesis, and glycogen metabolism. Am J Physiol 267:E710-E717, 1994
26. Sotsky MJ, Shilo S, Shamoon H: Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia. J Clin Endocrinol Metab 68:9-16, 1989
27. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420-430, 1959
28. Davis M, Mellman M, Friedman S, Chang CJ, Shamoon H: Recovery of epinephrine response but not hypoglycemic symptom threshold after intensive therapy in type 1 diabetes. Am J Med 97:535-542, 1994
29. Gabriely I, Wozniak R, Hawkins M, Shamoon H: Troglitazone amplifies counterregulatory responses to hypoglycemia in nondiabetic subjects. J Clin Endocrinol Metab 86:521-528, 2001
30. Petersen KF, Laurent D, Yu C, Cline GW, Shulman GI: Stimulating effects of low-dose fructose on insulin-stimulated hepatic glycogen synthesis in humans. Diabetes 50:1263-1268, 2001
31. Penicaud L, Cousin B, Leloup C, Lorsignol A, Casteilla L: The autonomic nervous system, adipose tissue plasticity, and energy balance. Nutrition 16:903-908, 2000
32. Levin BE, Dunn-Meynell AA, Routh VH: Brain glucose sensing and body energy homeostasis: role in obesity and diabetes. Am J Physiol 276:R1223-R1231, 1999
33. Borg MA, Sherwin RS, Borg WP, Tamborlane WV, Shulman GI: Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats. J Clin Invest 99:361-365, 1997
34. Borg WP, During MJ, Sherwin RS, Borg MA, Brines ML, Shulman GI: Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia. J Clin Invest 93:1677-1682, 1994
35. Borg WP, Sherwin RS, During MJ, Borg MA, Shulman GI: Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release. Diabetes 44:180-184, 1995
36. Agius L, Peak M: Binding and translocation of glucokinase in hepatocytes. Biochem Soc Trans 25:145-150, 1997
37. Agius L, Peak M, Van Schaftingen E: The regulatory protein of glucokinase binds to the hepatocyte matrix, but, unlike glucokinase, does not translocate during substrate stimulation. Biochem J 309 (Suppl.):711-713, 1995
38. Van Schaftingen E, Gerin I: The glucose-6-phosphatase system. Biochem J 362:513-532, 2002
39. Moore MC, Davis SN, Mann SL, Cherrington AD: Acute fructose administration improves oral glucose tolerance in adults with type 2 diabetes. Diabetes Care 24:1882-1887, 2001
40. Alvarez E, Roncero I, Chowen JA, Vazquez P, Blazquez E: Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain. J Neurochem 80:45-53, 2002
41. Banarer S, McGregor VP, Cryer PE: Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response. Diabetes 51:958-965, 2002
42. Bolli G, De Feo P, Perriello G, De Cosmo S, Compagnucci P, Santeusanio F, Brunetti P, Unger RH: Mechanisms of glucagon secretion during insulin-induced hypoglycemia in man: role of the beta cell and arterial hyperinsulinemia. J Clin Invest 73:917-922, 1984
43. Taborsky GJ Jr, Ahren B, Havel PJ: Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired α-cell responses in type 1 diabetes. Diabetes 47:995-1005, 1998
44. Hwang JH, Perseghin G, Rothman DL, Cline GW, Magnusson I, Petersen KF, Shulman GI: Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion: a 13C nuclear magnetic resonance spectroscopy study. J Clin Invest 95:783-787, 1995
45. Watt MJ, Hargreaves M: Effect of epinephrine on glucose disposal during exercise in humans: role of muscle glycogen. Am J Physiol Endocrinol Metab 283:E578-E583, 2002